Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO)
CUSIP: 87975F104
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, no par value
- Shares outstanding
- 34,382,284
- Total 13F shares
- 2,807,449
- Share change
- -895,323
- Total reported value
- $3,509,640
- Price per share
- $1.25
- Number of holders
- 42
- Value change
- -$1,509,843
- Number of buys
- 25
- Number of sells
- 30
Quarterly Holders Quick Answers
What is CUSIP 87975F104?
CUSIP 87975F104 identifies TELO - Telomir Pharmaceuticals, Inc. - Common Stock, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87975F104:
Top shareholders of TELO - Telomir Pharmaceuticals, Inc. - Common Stock, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bay Shore Trust |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
5,631,721
mixed-class rows
|
$20,414,715 | — | 21 Nov 2024 | |
| Christopher Chapman MD |
3/4/5
|
CEO & Chairman, Director |
—
class O/S missing
|
975,610
|
$6,048,782 | — | 08 Feb 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.7%
|
1,258,190
|
$4,063,954 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
3.5%
|
1,200,561
|
$3,877,812 | — | 31 Mar 2025 | |
| Craig Eagle |
3/4/5
|
Director |
—
class O/S missing
|
487,805
|
$3,024,391 | — | 08 Feb 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
429,252
|
$1,386,883 | — | 31 Mar 2025 | |
| Nathen Fuentes |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
101,134
|
$627,031 | — | 08 Feb 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.45%
|
154,072
|
$497,653 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.37%
|
125,673
|
$405,924 | — | 31 Mar 2025 | |
| Bradley Kroenig |
3/4/5
|
Director |
—
class O/S missing
|
48,781
|
$302,442 | — | 08 Feb 2024 | |
| Hugh Mccoll III |
3/4/5
|
Director |
—
class O/S missing
|
48,781
|
$302,442 | — | 08 Feb 2024 | |
| Talhia Tuck |
3/4/5
|
Director |
—
class O/S missing
|
48,781
|
$302,442 | — | 08 Feb 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.27%
|
91,353
|
$295,070 | — | 31 Mar 2025 | |
| Suncoast Equity Management |
13F
|
Company |
0.15%
|
51,194
|
$165,357 | — | 31 Mar 2025 | |
| Michelle Yanez |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
224,391
mixed-class rows
|
$151,224 | — | 27 Aug 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.13%
|
46,406
|
$149,891 | — | 31 Mar 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.13%
|
43,000
|
$138,890 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
32,282
|
$104,271 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
29,023
|
$93,744 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.07%
|
24,990
|
$80,718 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
23,699
|
$76,548 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.06%
|
20,339
|
$65,695 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.05%
|
16,080
|
$51,937 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
15,416
|
$49,794 | — | 31 Mar 2025 | |
| Atom Investors LP |
13F
|
Company |
0.04%
|
14,663
|
$47,361 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.04%
|
13,885
|
$44,848 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.04%
|
12,332
|
$39,832 | — | 31 Mar 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.03%
|
11,796
|
$38,101 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
11,732
|
$37,889 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.03%
|
11,167
|
$36,069 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
10,271
|
$33,175 | — | 31 Mar 2025 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.03%
|
9,472
|
$30,595 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
9,281
|
$29,978 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
9,064
|
$29,277 | — | 31 Mar 2025 | |
| Police & Firemen's Retirement System of New Jersey |
13F
|
Company |
0.02%
|
6,175
|
$19,945 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
2,717
|
$8,776 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.01%
|
1,938
|
$6,269 | — | 31 Mar 2025 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0%
|
1,454
|
$4,696 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
1,264
|
$4,083 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
817
|
$2,639 | — | 31 Mar 2025 | |
| CWM, LLC |
13F
|
Company |
0%
|
669
|
$2,000 | — | 31 Mar 2025 | |
| AMALGAMATED BANK |
13F
|
Company |
0%
|
667
|
$2,000 | — | 31 Mar 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
438
|
$1,730 | — | 31 Mar 2025 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
471
|
$1,521 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
446
|
$1,000 | — | 31 Mar 2025 | |
| NISA INVESTMENT ADVISORS, LLC |
13F
|
Company |
0%
|
183
|
$591 | — | 31 Mar 2025 | |
| Sterling Capital Management LLC |
13F
|
Company |
0%
|
148
|
$478 | — | 31 Mar 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0%
|
104
|
$336 | — | 31 Mar 2025 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0%
|
88
|
$284 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
3
|
$10 | — | 31 Mar 2025 |
Institutional Holders of Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO) as of Q2 2025
As of 30 Jun 2025,
Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,807,449 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, MARSHALL WACE, LLP, Y-Intercept (Hong Kong) Ltd, STATE STREET CORP, Bank of New York Mellon Corp, and Suncoast Equity Management.
This page lists
42
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
42
Q2 2025 holders
42
Holder diff
0
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.